IDiyas

For the Inventor, By the Inventor

Ibaraki, Japan

Shin-ichi Tsukamoto

USPTO Granted Patents = 12

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 71(Granted Patents)


Location History:

  • Tokyo, JP (1986 - 1995)
  • Ibaraki, JP (1995 - 2000)

Company Filing History:

goldMedal12 out of 329 
 
Yamanouchi Pharmaceutical Company Ltd.
 patents

Years Active: 1986-2000

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6133258 - Inhibitor of kainic acid neurotoxicity and pyridothiazine derivative (2000-10-17),
2. 6096743 - 1,2,3,4-tetrahydroquinoxalinedione derivative (2000-08-01),
3. 6090804 - Thiophene derivative and pharmaceutical composition thereof (2000-07-18),
4. 5686482 - N-(3-pyrrolidinyl) benzamide derivative (1997-11-11),
5. 5521180 - Morpholine derivative (1996-05-28),
6. 5412096 - Hydrochloride salts of heterocyclic spiro compounds (1995-05-02),
7. 5403931 - (-)-(S)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane L-tartrate (1995-04-04),
8. 5041549 - Heterocyclic spiro compounds and methods for preparing the same (1991-08-20),
9. 4996210 - Heterocyclic spiro compounds and methods for preparing the same (1991-02-26),
10. 4940795 - Heterocyclic spiro compounds and methods for preparing the same (1990-07-10),
11. 4719207 - CNS active substituted azetidinone compounds (1988-01-12),
12. 4629736 - Fatty acid derivatives and process of producing them (1986-12-16),

Title: The Innovative Mind of Shin-ichi Tsukamoto

Introduction: Shin-ichi Tsukamoto, a prominent inventor based in Ibaraki, Japan, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 12 patents, Tsukamoto is recognized for his work in neurotoxicity research and medicinal chemistry. His inventions highlight the intersection of innovation and healthcare, aiming to improve therapeutic outcomes.

Latest Patents: Among his latest patents, two particularly stand out: the "Inhibitor of Kainic Acid Neurotoxicity" and the "Pyridothiazine Derivative - 1,2,3,4-Tetrahydroquinoxalinedione Derivative." These patents reflect his ongoing commitment to addressing critical health issues through scientific exploration and innovation.

Career Highlights: Tsukamoto's career has been defined by his role at Yamanouchi Pharmaceutical Company Ltd., where he has honed his skills and contributed to numerous research initiatives. His relentless pursuit of knowledge and improvement in pharmaceutical applications has made him a key figure in his company.

Collaborations: Throughout his career, Tsukamoto has collaborated with esteemed colleagues, including Toshinari Tamura and Hitoshi Nagaoka. These partnerships have not only enhanced the quality of his work but have also fostered an environment of creativity and shared knowledge within the pharmaceutical community.

Conclusion: Shin-ichi Tsukamoto is a testament to the power of innovation in the field of pharmaceuticals. Through his patents and collaborative efforts, he continues to pave the way for advancements that have the potential to change lives. His journey is an inspiration for aspiring inventors and researchers dedicated to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…